Preliminary results from a small study of heavily treated patients with blood cancer suggest that an experimental protein ...
Combined with chemotherapy and immunotherapy, AstraZeneca's Calquence reduced the risk of disease progression or death by 27% ...
A Gilead cancer drug whose developments have essentially been halted not only failed to improve survival odds for blood ...
Roche released detailed data at the European Hematology Association congress for its CD20xCD3 bispecific antibody Columvi in ...
The Congressional Budget Office predicted that a patent reform bill introduced last year could result in federal savings of ...
The FDA is directing Covid-19 vaccine manufacturers to update their formulations to target the KP.2 strain of the virus, ...
Ultragenyx moved one step closer to establishing a new surrogate biomarker for accelerated approval in rare disease gene ...
Innovent Biologics has lifted the curtain on late-stage data from its next-generation “double-G” drug in overweight or obese ...
Bill Haney has helped Skyhawk Therapeutics stand out in the wave of biotechs looking to drug RNA, taking over from fellow ...
The radioisotope lutetium-177 is at risk of slipping into shortage due to rapidly increasing demand, outdated manufacturing ...
The Supreme Court has unanimously rejected an attempt by doctors and anti-abortion groups to limit the use of the abortion ...
The FDA on Thursday heard feedback from a slew of stakeholders on potential upcoming changes to the advisory committee ...